On Friday, the FDA approved Bayer’s dual neurokinin (NK) targeted therapy elinzanetant, which will now be marketed in the U.S ...
Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant) 60mg capsules, the ...
Cardiovascular disease risk may be attributed to factors beyond changes in estrogen among women undergoing the menopause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback